A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors

The use of monoclonal antibodies (mAb) for the diagnosis and treatment of malignancies is acquiring an increasing clinical importance, thanks to their specificity, efficacy and relative easiness of use. However, in the context of Epstein-Barr virus (EBV)-related malignancies, only cancers of B-cell...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncoimmunology
Главные авторы: Turrini, Riccardo, Merlo, Anna, Martorelli, Debora, Faè, Damiana Antonia, Sommaggio, Roberta, Montagner, Isabella Monia, Barbieri, Vito, Marin, Oriano, Zanovello, Paola, Dolcetti, Riccardo, Rosato, Antonio
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis 2017
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5414862/
https://ncbi.nlm.nih.gov/pubmed/28507812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1304338
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы